mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
6e-05 |
mRNA |
Nutlin-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0002 |
mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0003 |
mRNA |
MLN4924 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0003 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0004 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0005 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.0006 |
mRNA |
narciclasine |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0008 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.099 |
0.0008 |
mRNA |
PF-3758309 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.0009 |